Single Dose of pGM169/GL67A in CF Patients
NCT00789867
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Cystic Fibrosis
Interventions
DRUG:
pGM169/GL67A
Sponsor
Imperial College London
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]